Quellennachweise  
  Psychopharmaka lösen ein chemisches Ungleichgewicht erst aus, verschlimmern Erkrankungen und halten die Patienten in ihrer Erkrankung

Hengartner, M.P., J. Angst, und W. Rossler, Antidepressant Use Prospectively Relates to a Poorer Long-Term Outcome of Depression: Results from a Prospective Community Cohort Study over 30 Years. Psychother Psychosom, 2018.

Van Scheyen JD, 1973, Recurrent vital depressions, Psychiatria, Neurologia, Neurochirurgia 76 (1973): 93-112

7 47. Shea M T,1992, Course of symptoms over follow-up, Arch Gen Psychiatry 49:782-87.

Fava G,1994, Do antidepressant and antianxiety drugs increase chronicity in affective disorders?, Psychotherapy and Psychosomatics 61:125-31

Fava G, 2003, Can long-term treatment with antidepressant drugs worsen the course of depression?,
J Clin Psychiatry 64: 123-33 50. Viguera AC , 1998, ‘Discontinuing antidepressant treatment in major depression’, Harvard Review of Psychiatry 5:293-305

Weel-Baumgarten E, 2000, Treatment of depression related to recurrence, J Clin Pharmacy and Therapeutics, 25:61-66

Coryell W, 1995, Characteristics and significance of untreated major depressive disorder, AJP 152:1124-29

Andrews, P., et al., Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology, 2011. 2.

El-Mallakh, R.S., Y. Gao, und R. Jeannie Roberts, Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression. Med Hypotheses, 2011. 76(6): p. 769-73.

Eine Langzeiteinnahme von Antipsychotika verbittet sich/Akuttherapie bietet große Heilungschancen

https://pubmed.ncbi.nlm.nih.gov/25066792/

https://pubmed.ncbi.nlm.nih.gov/17502806/

https://academic.oup.com/schizophreniabulletin/article/31/3/723/1894450

Lebenszeitverkürzung durch Psychopharmaka

Die finnische Registerstudie (Tiihionen et al 2009)

Haddad et al 2002, Hennessy et al 2002, Ray et al 2001, Ray et al 2009)

(Ray et al 2001)

(Correll et al 2006)

(Stahl et al 2009, Holt et al 2004)

(Jin et al 2004, Newcomer et al 2006, Gianfrancesco et al 2002, Buse et al 2003)

(Weinmann et al 2009)

(Brown et al 2010)

Die FIN 11 Studie (Tiihonen et al 2009) und Methodenkritik (de Hert et al 2010)

Serotonitheorie nie belegt

Praschak-Rieder, N., et al., Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.Biol Psychiatry, 2004. 56(8): p. 587-91.

Lacasse, J.R. und J. Leo, Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med, 2005. 2(12): p. e392.

Becker, U., et al., Direktes Serotonin (5-HT) im Liquor psychiatrischer Patienten, in Aktuelle Perspektiven der Biologischen Psychiatrie, H.J. Möller, F. Müller-Spahn, and G. Kurtz, Editors. 1996, Springer Vienna, p. 161-165.

Andrews, P.W., et al., Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci Biobehav Rev, 2015. 51: p. 164-188.

Fattaccini, C.M., et al., Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology, 1990. 29(1): p. 1-8

Wirkung AD wie Placebo

Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

Zusammenfassung der Ergebnisse der Placebostudien von Kirsch in Unglück auf Rezept: Die Antidepressivalüge und ihre Folgen von Peter und Sabine Ansari

Beitrag Schweizer Fernsehen: Antidepressiva nicht besser als Placebo von depression-heute.de zur Übersichtsstudie des Nordic Cochrane Centre

Antidepressants and the Placebo Effect. Kirsch Irving.

Placebo Effect in the Treatment of Depression and Anxiety. Kirsch Irving.

https://www.dgsp-ev.de/fileadmin/user_files/dgsp/pdfs/Stellungnahmen/Der_Stellenwert_antidepressiver_Medikamente_Stellungnahme_DGSP_Oktober_2017.pdf

Arznei-Telegramm 2018; Jg. 49, Nr. 5, p. 41-43

Jacobsen JC et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017 Feb 8;17(1):58.

Pigott, H.E., STAR*D: A Tale and Trail of Bias. Ethical Human Psychology and Psychiatry, 2011. 13(1): p. 6-28.Kirsch, I., et al., Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med, 2008. 5(2), p. e45. 20. Fournier, J.C., et al., Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA, 2010. 303(1), p. 47-53.

Rabinowitz, J., et al., Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials. Br J Psychiatry, 2016. 209(5), p. 427-428.

Turner, E.H., et al., Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med, 2008. 358. Anpassung des Gehirnes und Serotonindefizit als Resultat der Antidepressiva

Alternativen zu Neuroleptika

https://extendedroom.org/en/visiting-the-medication-free-psychiatric-ward-in-tromso/?fbclid=IwAR3cLbkO6_P9yN3XhCFgpa5bu97yx_h5yPjLysHFBq8jw8l85McEbROzr9s

http://www.offener-dialog.de/

http://open-dialogue.net/

Auslöser von psychischen Erkrankungen = u.a. toxisches soziales Umfeld, Beruf, Stress

https://www.spektrum.de/news/schizophrenie-gibt-es-nicht/1682902?fbclid=IwAR0ikZXNvuLXfh8K_XxFILfWqu2lwBsUaSM7m1-NcLBJXu8kO-hN5rOVorw

Ein Großteil der Depressionen heilt von alleine aus

Spijker, J., Graaf, R. de, Bijl, R.V., Beekman, A.T.F., Ormel, J. und W.A. Nolen, Duration of major depressive episodes in the general population: results fromThe Netherlands Mental Health Survey and Incidence Study (NEMESIS). British Journal of Psychiatry, 2002. 181: p. 208-213.

Whiteford, H.A., M. G. Harris, M.G,, , G. McKeon, G., Baxter, A., Pennell, C., J. Barendregt, J. und J. Wang, Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological Medicine, 2013. 43: p. 1569–1585.
 
    back to navigation
 

© 2020 psychiatriegeschaedigte-deutschland.de - Design und Konzept R. Dellhofen